litlas
Log inCreate account

Gus A. Baker

Active 1984–2025

Also published as
Gus A Baker
112
Papers
19,869
Citations
83
h-index
110
i10-index

Citations

Citations per year for Gus A. Baker1986: 1 citations1988: 1 citations1989: 1 citations1990: 1 citations1991: 1 citations1992: 7 citations1993: 12 citations1994: 11 citations1995: 25 citations1996: 33 citations1997: 49 citations1998: 45 citations1999: 58 citations2000: 80 citations2001: 65 citations2002: 71 citations2003: 108 citations2004: 79 citations2005: 116 citations2006: 84 citations2007: 112 citations2008: 114 citations2009: 121 citations2010: 86 citations2011: 166 citations2012: 151 citations2013: 149 citations2014: 164 citations2015: 131 citations2016: 142 citations2017: 108 citations2018: 123 citations2019: 471 citations2020: 415 citations2021: 422 citations2022: 309 citations2023: 169 citations2024: 400 citations2025: 119 citations2026: 9 citations1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,082 citing papers, 22.5% of this breakdownUnited Kingdom: 676 citing papers, 14% of this breakdownGermany: 246 citing papers, 5.1% of this breakdownAustralia: 231 citing papers, 4.8% of this breakdownItaly: 225 citing papers, 4.7% of this breakdownCanada: 220 citing papers, 4.6% of this breakdownNetherlands: 176 citing papers, 3.7% of this breakdownChina: 174 citing papers, 3.6% of this breakdownFrance: 153 citing papers, 3.2% of this breakdownSweden: 118 citing papers, 2.4% of this breakdownIndia: 85 citing papers, 1.8% of this breakdownNorway: 85 citing papers, 1.8% of this breakdown
0%22.5%Other 27.8%

Institutions

Fields

  • Medicine81.8%
  • Neuroscience11%
  • Biochemistry, Genetics and Molecular Biology2.3%
  • Psychology1.5%
  • Health Professions1.3%
  • Economics, Econometrics and Finance0.7%
  • Other1.4%

Topics

  • Epilepsy research and treatment21.5%
  • Pharmacological Effects and Toxicity Studies16.1%
  • Psychosomatic Disorders and Their Treatments7.4%
  • Neuroscience and Neuropharmacology Research3.2%
  • Pregnancy and Medication Impact3.1%
  • EEG and Brain-Computer Interfaces2.3%
  • Other46.4%

Coauthors

All papers

Open in search
  1. Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: A staged approach

    Authors: W. Curt LaFrance, Gus A. Baker, Rod Duncan, Laura H. Goldstein, Markus Reuber - Epilepsia 2013 cited by 830

  2. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

    Authors: Kimford J. Meador, Gus A. Baker, N. Andrew Browning, Morris J. Cohen, Rebecca Bromley, Jill Clayton‐Smith, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring - The Lancet Neurology 2013 cited by 831

  3. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

    Authors: Anthony G Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme J. Sills, Catrin Tudur Smith, Catrin Plumpton, Dyfrig Hughes, Paula Williamson, Gus A. Baker, Silviya Balabanova, Claire Taylor, Richard Brown, D Hindley, Stephen Howell, Melissa Maguire, Rajiv Mohanraj, Phil E M Smith, Karen Lanyon, Mark Manford, Manali Chitre, Alasdair Parker, Nina Swiderska, Richard Appleton, James Pauling, Adrian Hughes, Rajat Das Gupta, Sadia Hanif, Mostafa Awadh, Sharmini Ragunathan, Nicola Cable, Paul Cooper, Daniel Hindley, Karl Rakshi, Sophie Molloy, Markus Reuber, Kunle Ayonrinde, Martin Wilson, Satyanarayana Saladi, John Gibb, Lesley-Ann Funston, Damhait Cassidy, Jonathan Boyd, Mal Ratnayaka, Hani Faza, Martin Sadler, Hassan Al-Moasseb, Clare Galtrey, Damien Wren, Anas Olabi, Geraint Fuller, Muhammed Khan, Chetana Kallappa, Ravi Chinthapalli, Baba Aji, Rhys Davies, Kathryn A. Foster, Nikolas Hitiris, Melissa Maguire, Nahin Hussain, Simon Dowson, Julie Ellison, Basil Sharrack, Vandna Gandhi, Robert Powell, Phil Tittensor, Beatrice A. Summers, Sastry Shashikiran, Penelope J Dison, Shanika Samarasekera, Doug McCorry, Kathleen M. White, Kannan Nithi, Martin Richardson, Richard Brown, Rupert Page, David Deekollu, Sean Slaght, Stephen Warriner, Mansoor Ahmed, Abhijit Chaudhuri, Gabriel Chow, Javier Carod Artal, Danute Kucinskiene, Harish Sreenivasa, Singara Velmurugan, Christos Zipitis, Brendan McLean, Vaithianathar Lal, Angelous Gregoriou, Paul Maddison, Trevor Pickersgill, Joseph Anderson, Charlotte Lawthom, Stephen Howell, Gabriel Whitlingum, Wojtek Rakowicz, Lucy Kinton, Alisa McLellan and 34 more - The Lancet 2021 cited by 211

  4. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

    Authors: Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, Richard Appleton, Gus A. Baker, David Chadwick, Celia Cramp, O.C. Cockerell, Paul Cooper, Julie Doughty, Barbara Eaton, Carrol Gamble, Peter Goulding, Stephen Howell, Adrian Hughes, Margaret Jackson, Ann Jacoby, Mark Kellett, Geoffrey R Lawson, John Paul Leach, Paola Nicolaides, Richard Roberts, Phil Shackley, Jing Shen, David F. Smith, Phil E M Smith, Catrin Tudur Smith, Alessandra Vanoli, Paula Williamson - The Lancet 2007 cited by 970

  5. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

    Authors: Rebecca Bromley, G. E. Mawer, Michelle Briggs, Christopher P. Cheyne, Jill Clayton‐Smith, Marta García‐Fiñana, Rachel Kneen, S. B. Lucas, Rebekah Shallcross, Gus A. Baker, On Behalf of the Liverpool and Manchester Neurodevelopment Group, Gus A. Baker, Michelle Briggs, Rebecca Bromley, Jill Clayton‐Smith, Pete Dixon, Alan Fryer, Alison Gummery, Rachel Kneen, Lydia Kerr, S. B. Lucas, G. E. Mawer, Rebekah Shallcross - Journal of Neurology Neurosurgery & Psychiatry 2013 cited by 365

  6. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

    Authors: Anthony G Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme J. Sills, Catrin Tudur Smith, Catrin Plumpton, Dyfrig Hughes, Paula Williamson, Gus A. Baker, Silviya Balabanova, Claire Taylor, Richard Brown, D Hindley, Stephen Howell, Melissa Maguire, Rajiv Mohanraj, Phil E M Smith, Karen Lanyon, Mark Manford, Manali Chitre, Alasdair Parker, Nina Swiderska, Richard Appleton, James Pauling, Adrian Hughes, Rajat Das Gupta, Sadia Hanif, Mostafa Awadh, Sharmini Ragunathan, Nicola Cable, Paul Cooper, Daniel Hindley, Karl Rakshi, Sophie Molloy, Markus Reuber, Kunle Ayonrinde, Martin Wilson, Satyanarayana Saladi, John Gibb, Lesley-Ann Funston, Damhait Cassidy, Jonathan Boyd, Mal Ratnayaka, Hani Faza, Martin Sadler, Hassan Al-Moasseb, Clare Galtrey, Damien Wren, Anas Olabi, Geraint Fuller, Muhammed Khan, Chetana Kallappa, Ravi Chinthapalli, Baba Aji, Rhys Davies, Kathryn A. Foster, Nikolas Hitiris, Melissa Maguire, Nahin Hussain, Simon Dowson, Julie Ellison, Basil Sharrack, Vandna Gandhi, Robert Powell, Phil Tittensor, Beatrice A. Summers, Sastry Shashikiran, Penelope J Dison, Shanika Samarasekera, Doug McCorry, Kathleen M. White, Kannan Nithi, Martin Richardson, Richard Brown, Rupert Page, David Deekollu, Sean Slaght, Stephen Warriner, Mansoor Ahmed, Abhijit Chaudhuri, Gabriel Chow, Javier Carod Artal, Danute Kucinskiene, Harish Sreenivasa, Singara Velmurugan, Christos Zipitis, Brendan McLean, Vaithianathar Lal, Angelous Gregoriou, Paul Maddison, Trevor Pickersgill, Joseph Anderson, Charlotte Lawthom, Stephen Howell, Gabriel Whitlingum, Wojtek Rakowicz, Lucy Kinton, Alisa McLellan and 34 more - The Lancet 2021 cited by 191

  7. Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review

    Authors: Rod S Taylor, Josemir W. Sander, Rebecca J. Taylor, Gus A. Baker - Epilepsia 2011 cited by 387

  8. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

    Authors: Anthony G Marson, Asya M Al-Kharusi, Muna Alwaidh, Richard Appleton, Gus A. Baker, David Chadwick, Celia Cramp, O.C. Cockerell, Paul Cooper, Julie Doughty, Barbara Eaton, Carrol Gamble, Peter Goulding, Stephen Howell, Adrian Hughes, Margaret Jackson, Ann Jacoby, Mark Kellett, Geoffrey R Lawson, John Paul Leach, Paola Nicolaides, Richard Roberts, Phil Shackley, Jing Shen, David F. Smith, Phil E M Smith, Catrin Tudur Smith, A Vanoli, Paula Williamson - The Lancet 2007 cited by 976

  9. Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013–2017

    Authors: Sarah J. Wilson, Sallie Baxendale, William Barr, Sherifa A. Hamed, John T. Langfitt, Séverine Samson, Masako Watanabe, Gus A. Baker, Christoph Helmstaedter, Bruce P. Hermann, Mary‐Lou Smith - Epilepsia 2015 cited by 208

  10. Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

    Authors: Kimford J. Meador, Gus A. Baker, N. Andrew Browning, Jill Clayton‐Smith, Deborah T. Combs‐Cantrell, Morris J. Cohen, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring - New England Journal of Medicine 2009 cited by 818

  11. IQ at 6 years after in utero exposure to antiepileptic drugs

    Authors: Gus A. Baker, Rebecca Bromley, Maria Briggs, Christopher P. Cheyne, Morris J. Cohen, Marta García‐Fiñana, Alison Gummery, Rachel Kneen, David W. Loring, George Mawer, Kimford J. Meador, Rebekah Shallcross, Jill Clayton‐Smith, Claire Barrie, John R. Beech, Alison Booth, Pete Dixon, Alan Fryer, Loretta Kerr - Neurology 2014 cited by 266

  12. Quality of Life of People with Epilepsy: A European Study

    Authors: Gus A. Baker, Ann Jacoby, Deborah Buck, Carlos Stalgis, Dominique L. Monnet - Epilepsia 1997 cited by 841

  13. Semantic memory is impaired in patients with unilateral anterior temporal lobe resection for temporal lobe epilepsy

    Authors: Matthew A. Lambon Ralph, Shoaib Ehsan, Gus A. Baker, Timothy T. Rogers - Brain 2012 cited by 172

  14. Characteristics associated with quality of life among people with drug-resistant epilepsy

    Authors: SMILE Team, Leone Ridsdale, Gabriella Wojewodka, Emily Robinson, Sabine Landau, Adam Noble, Stephanie Taylor, Mark P. Richardson, Gus A. Baker, Laura H. Goldstein - Journal of Neurology 2017 cited by 104

  15. National plans and awareness campaigns as priorities for achieving global brain health

    Authors: Sebastian Winter, Donna Walsh, Coriene E. Catsman‐Berrevoets, Valery L. Feigin, Frédéric Destrebecq, Suzanne L. Dickson, Matilde Leonardi, Volker Hoemberg, Cristina Tassorelli, Maria Teresa Ferretti, Anna Dé, Antonella Santuccione Chadha, Chris Lynch, Sophia Bakhtadze, Deanna Saylor, Soonmyung Hwang, Kevin Rostásy, Benzi M. Kluger, Claire Wright, Phyllis C. Zee, David W. Dodick, Joke Jaarsma, Mayowa Owolabi, Jelka Zaletel, Tit Albreht, Rajinder K. Dhamija, Anne Helme, Joanna Laurson-Doube, Action Amos, Florence Baingana, Gus A. Baker, Francesca Sofia, Orla Galvin, Tadeusz Hawrot - The Lancet Global Health 2024 cited by 33

  16. Systematic screening allows reduction of adverse antiepileptic drug effects

    Authors: Frank Gilliam, A. James Fessler, Gus A. Baker, Victoria Vahle, J. Carter, Hrayr Attarian - Neurology 2004 cited by 338

  17. The Psychosocial Burden of Epilepsy

    Authors: Gus A. Baker - Epilepsia 2002 cited by 215

  18. Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years

    Authors: Morris J. Cohen, Kimford J. Meador, N. Andrew Browning, Ryan May, Gus A. Baker, Jill Clayton‐Smith, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring - Epilepsy & Behavior 2013 cited by 176

  19. Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate

    Authors: Rebecca Bromley, Rebecca Calderbank, Christopher P. Cheyne, Claire Rooney, Penny Trayner, Jill Clayton‐Smith, Marta García‐Fiñana, Beth Irwin, James Morrow, Rebekah Shallcross, Gus A. Baker - Neurology 2016 cited by 130

  20. Indications and expectations for neuropsychological assessment in epilepsy surgery in children and adults

    Authors: Sallie Baxendale, Sarah J. Wilson, Gus A. Baker, William Barr, Christoph Helmstaedter, Bruce P. Hermann, John T. Langfitt, Gitta Reuner, Patrícia Rzezak, Séverine Samson, Mary-Lou Smith - Epileptic Disorders 2019 cited by 85

  21. The Clinical Course of Epilepsy and Its Psychosocial Correlates: Findings from a U.K. Community Study

    Authors: Ann Jacoby, Gus A. Baker, Nick Steen, Pauline Potts, David Chadwick - Epilepsia 1996 cited by 631

  22. Breastfeeding in Children of Women Taking Antiepileptic Drugs

    Authors: Kimford J. Meador, Gus A. Baker, N. Andrew Browning, Morris J. Cohen, Rebecca Bromley, Jill Clayton‐Smith, Laura A. Kalayjian, Andrés M. Kanner, Joyce Liporace, Page B. Pennell, Michael Privitera, David W. Loring - JAMA Pediatrics 2014 cited by 223

  23. Psychogenic non-epileptic seizures—Definition, etiology, treatment and prognostic issues: A critical review

    Authors: Nynke M.G. Bodde, Jayne Brooks, Gus A. Baker, Paul Boon, J. Hendriksen, O. G. Mulder, Albert P. Aldenkamp - Seizure 2009 cited by 318

  24. In utero antiepileptic drug exposure

    Authors: Kimford J. Meador, Gus A. Baker, Richard H. Finnell, Laura A. Kalayjian, Joyce Liporace, David W. Loring, G. E. Mawer, Page B. Pennell, J. CAMPBELL SMITH, Markus Wolff - Neurology 2006 cited by 276